Tebbutt NC - Search Results

1

A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer.

Tebbutt NC, Norman A, Cunningham D, Iveson T, Seymour M, Hickish T, Harper P, Maisey N, Mochlinski K, Prior Y, Hill M. Tebbutt NC, et al. Ann Oncol. 2002 Oct;13(10):1568-75. doi: 10.1093/annonc/mdf273. Ann Oncol. 2002. PMID: 12377644 Free article. Clinical Trial.

2

Standard chemotherapy for gastric carcinoma: is it a myth?

Tebbutt NC, Norman A, Hill M, Cunningham D. Tebbutt NC, et al. J Clin Oncol. 2001 May 15;19(10):2765-7. doi: 10.1200/JCO.2001.19.10.2765. J Clin Oncol. 2001. PMID: 11352971 No abstract available.

3

Systemic treatment of colorectal cancer.

Tebbutt NC, Cattell E, Midgley R, Cunningham D, Kerr D. Tebbutt NC, et al. Eur J Cancer. 2002 May;38(7):1000-15. doi: 10.1016/s0959-8049(02)00062-x. Eur J Cancer. 2002. PMID: 11978525 Review.

4

Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancer.

Maisey N, Chau I, Cunningham D, Norman A, Seymour M, Hickish T, Iveson T, O'Brien M, Tebbutt N, Harrington A, Hill M. Maisey N, et al. J Clin Oncol. 2002 Jul 15;20(14):3130-6. doi: 10.1200/JCO.2002.09.029. J Clin Oncol. 2002. PMID: 12118027 Clinical Trial.

5

Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases.

Tebbutt NC, Norman AR, Cunningham D, Hill ME, Tait D, Oates J, Livingston S, Andreyev J. Tebbutt NC, et al. Gut. 2003 Apr;52(4):568-73. doi: 10.1136/gut.52.4.568. Gut. 2003. PMID: 12631671 Free PMC article.

6

The role of surveillance CT scans in patients with diffuse large B-cell non-Hodgkin's lymphoma.

Guppy AE, Tebbutt NC, Norman A, Cunningham D. Guppy AE, et al. Among authors: tebbutt nc. Leuk Lymphoma. 2003 Jan;44(1):123-5. doi: 10.1080/1042819021000040323. Leuk Lymphoma. 2003. PMID: 12691151

7

Analysis of the time course and prognostic factors determining toxicity due to infused fluorouracil.

Tebbutt NC, Norman AR, Cunningham D, Allen M, Chau I, Oates J, Hill M. Tebbutt NC, et al. Br J Cancer. 2003 May 19;88(10):1510-5. doi: 10.1038/sj.bjc.6600917. Br J Cancer. 2003. PMID: 12771914 Free PMC article.

8

Mitomycin C, carboplatin and protracted venous infusion 5-fluorouracil in advanced oesophago-gastric and pancreatic cancer: results of two phase II studies.

Kelleher M, Tebbutt NC, Cunningham D, Andreyev J, Allen M, Hill M, Norman A. Kelleher M, et al. Among authors: tebbutt nc. Clin Oncol (R Coll Radiol). 2003 May;15(3):92-7. doi: 10.1053/clon.2002.0173. Clin Oncol (R Coll Radiol). 2003. PMID: 12801044 Clinical Trial.

9

The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.

Chau I, Allen MJ, Cunningham D, Norman AR, Brown G, Ford HE, Tebbutt N, Tait D, Hill M, Ross PJ, Oates J. Chau I, et al. J Clin Oncol. 2004 Apr 15;22(8):1420-9. doi: 10.1200/JCO.2004.05.041. Epub 2004 Mar 8. J Clin Oncol. 2004. PMID: 15007086 Clinical Trial.

10

Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer.

Rao S, Cunningham D, Price T, Hill ME, Ross PJ, Tebbutt N, Norman AR, Oates J, Shellito P. Rao S, et al. Br J Cancer. 2004 Aug 31;91(5):839-43. doi: 10.1038/sj.bjc.6602039. Br J Cancer. 2004. PMID: 15266319 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters